Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-010477

President sold 30,000 shares at an average $63.12 ($1,893,554)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-02-10 Option exercise +15,000 $6.55 $98,250 15,000 D: show line 1 in the form
RUBINSTEIN JULIE President 2021-02-10 Sale −6,770 $62.14 $420,688 8,230 D: show line 2 in the form
RUBINSTEIN JULIE President 2021-02-10 Sale −3,814 $63.00 $240,282 4,416 D: show line 3 in the form
RUBINSTEIN JULIE President 2021-02-10 Sale −3,798 $64.09 $243,414 618 D: show line 4 in the form
RUBINSTEIN JULIE President 2021-02-10 Sale −618 $64.76 $40,022 0 D: show line 5 in the form
RUBINSTEIN JULIE President 2021-02-11 Option exercise +15,000 $6.55 $98,250 15,000 D: show line 6 in the form
RUBINSTEIN JULIE President 2021-02-11 Sale −10,729 $63.12 $677,214 4,271 D: show line 7 in the form
RUBINSTEIN JULIE President 2021-02-11 Sale −4,271 $63.67 $271,935 0 D: show line 8 in the form
Open-market sales · 30,000 sh · avg $63.12 · $1,893,554

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-02-10 Option exercise · Stock Option (Right to Buy) −15,000 375,000 D: show line 9 in the form
RUBINSTEIN JULIE President 2021-02-11 Option exercise · Stock Option (Right to Buy) −15,000 360,000 D: show line 10 in the form
Loading xslF345X03/doc4.xml…